"During the year ended December 31, 2018, net cash used in operating activities was $4,400,965 and net cash used in investing activities was $1,432,363, which was due primarily to the Company’s research and development activities and general and administrative expenditures. Net cash provided by financing activities for the year ended December 31, 2018 was $4,525,626. At December 31, 2018, our cash and cash equivalents totaled $2,174,625, our assets totaled $5,251,264, our liabilities totaled $344,202, and we had stockholders’ equity of $4,907,062."